Overview

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
Treatment of actinic keratosis with imiquimod cream is expected to cause changes in the genes that are turned on, and turned off, by skin cells. Some of the drug induced changes in skin cells should also be visible using a special microscope. This study examines both types of changes.
Phase:
Phase 2
Details
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Treatments:
Imiquimod